Satsuma Pharmaceuticals Inc (STSA)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

400 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO, CA 64080

Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company developing a novel therapeutic product candidate for the acute treatment of migraine. Its product candidate, STS101, is a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, or DHE, which is designed to be quickly and easily self-administered with a proprietary pre-filled, single-use, nasal delivery device. DHE products have long been recommended as a first-line therapeutic option for the acute treatment of migraine and have significant advantages over other therapeutics for many patients. However, broad use has been limited by invasive and burdensome administration and/or sub-optimal clinical performance of available injectable and liquid nasal spray products. STS101 is in Phase 3 development and specifically designed to deliver the clinical advantages of DHE while overcoming these shortcomings.

Data as of 2021-10-17 10:29:54 -0400
Market Cap154.494 Million Shares Outstanding31.529 Million Avg 30-day Volume89.738 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-2.53 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.04808 52-week High/Low7.48 / 3.5 Next Earnings Date2021-11-09 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from STSA instead.

View recent insider trading info

Funds Holding STSA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding STSA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

162.2 Thousand total shares from 2 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

COMMODORE CAPITAL LP

  • 10% Owner
3,370,955 2021-10-15 2

HARSCH MUTYA

  • Director
40,000 2021-10-11 2

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

SHAH RAJEEV M.

  • Director
  • 10% Owner
5,914,252 2021-04-01 2

KING THOMAS BRAXTON

  • Director
0 2020-12-03 1

ALBRECHT DETLEF CHIEF MEDICAL OFFICER

  • Officer
0 2020-12-03 1

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

  • Director
  • 10% Owner
0 2020-12-03 1

KOLLINS JOHN A PRESIDENT AND CEO

  • Officer
  • Director
0 2020-12-03 1

SOLOWAY THOMAS P

  • Director
0 2020-12-03 1

LUKATCH HEATH

  • Director
0 2020-12-03 1

SHAH RAJEEV M.

  • Director
  • 10% Owner
0 2020-12-03 1

SANDOVAL ELISABETH

  • Director
0 2020-12-03 1

O'NEIL THOMAS P. CHIEF FINANCIAL OFFICER

  • Officer
0 2020-12-03 1

TAKANASHI KEN

  • Director
1,561,719 2020-12-03 1

RIEBE MICHAEL T

  • Director
0 2020-12-03 1

TPG GROUP HOLDINGS (SBS) ADVISORS, INC.

BONDERMAN DAVID

COULTER JAMES G

  • 10% Owner
1,885,939 2019-09-17 0

HADLEY HARBOR MASTER INVESTORS (CAYMAN) II L.P.

  • 10% Owner
No longer subject to file 2019-09-17 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

COMMODORE CAPITAL LP - > 10% Owner by commodore capital master lp

2021-10-19 17:13:59 -0400 2021-10-18 P 36,194 $4.87 a 3,370,955 indirect

COMMODORE CAPITAL LP - > 10% Owner by commodore capital master lp

2021-10-19 17:13:59 -0400 2021-10-15 P 126,000 $4.83 a 3,334,761 indirect

HARSCH MUTYA - Director

2021-10-12 17:17:04 -0400 2021-10-11 A 40,000 a 40,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SATSUMA PHARMACEUTICALS INC STSA 2021-10-20 22:15:03 UTC -0.4244 0.4944 700000
SATSUMA PHARMACEUTICALS INC STSA 2021-10-20 21:45:03 UTC -0.4244 0.4944 700000
SATSUMA PHARMACEUTICALS INC STSA 2021-10-20 21:15:03 UTC -0.4244 0.4944 700000
SATSUMA PHARMACEUTICALS INC STSA 2021-10-20 20:45:03 UTC -0.4244 0.4944 700000
SATSUMA PHARMACEUTICALS INC STSA 2021-10-20 20:15:03 UTC -0.4244 0.4944 700000
SATSUMA PHARMACEUTICALS INC STSA 2021-10-20 19:45:04 UTC -0.4244 0.4944 700000
SATSUMA PHARMACEUTICALS INC STSA 2021-10-20 19:15:03 UTC -0.4244 0.4944 700000
SATSUMA PHARMACEUTICALS INC STSA 2021-10-20 18:45:03 UTC -0.4261 0.4961 700000
SATSUMA PHARMACEUTICALS INC STSA 2021-10-20 18:15:04 UTC -0.4261 0.4961 700000
SATSUMA PHARMACEUTICALS INC STSA 2021-10-20 17:45:03 UTC -0.4261 0.4961 700000
SATSUMA PHARMACEUTICALS INC STSA 2021-10-20 17:15:03 UTC -0.4261 0.4961 700000
SATSUMA PHARMACEUTICALS INC STSA 2021-10-20 16:45:03 UTC -0.4258 0.4958 700000
SATSUMA PHARMACEUTICALS INC STSA 2021-10-20 16:15:04 UTC -0.4258 0.4958 700000
SATSUMA PHARMACEUTICALS INC STSA 2021-10-20 15:45:03 UTC -0.4258 0.4958 700000
SATSUMA PHARMACEUTICALS INC STSA 2021-10-20 15:15:03 UTC -0.4258 0.4958 700000
SATSUMA PHARMACEUTICALS INC STSA 2021-10-20 14:45:03 UTC -0.4295 0.4995 700000
SATSUMA PHARMACEUTICALS INC STSA 2021-10-20 14:15:03 UTC -0.4295 0.4995 700000
SATSUMA PHARMACEUTICALS INC STSA 2021-10-20 13:45:03 UTC -0.4295 0.4995 750000
SATSUMA PHARMACEUTICALS INC STSA 2021-10-20 13:15:03 UTC -0.4295 0.4995 750000
SATSUMA PHARMACEUTICALS INC STSA 2021-10-20 12:45:03 UTC -0.4295 0.4995 750000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund STSA -3.0 shares, $-64.56 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund STSA -4.0 shares, $-86.08 2020-03-31 N-PORT

Elevate your investments